B cells and humoral immunity in melanoma: regulatory and autoimmune-like features and implications for immunotherapy
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
Europe PMC Europe PMC 1 Sign in | Create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Governance & funding Mission & roadmap Outreach Tools Tools overview Article status monitor ORCID article claiming Grant finder External links service RSS feeds About SciLite annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API case studies SOAP web service Annotations API OAI service Bulk downloads Developers Forum Support User guide Search syntax guide Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus
Related documents
- Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma#272354
- The pathogenic role of double-negative B cells in autoimmune diseases.#446101
- TCR repertoire and HLA genotype as response biomarkers to checkpoint blockade immunotherapy in advanced melanoma patients#211995
- A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma#394762
- Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma#892512
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive